A comparison of nesiritide vs. epoprostenol in a patient with precapillary pulmonary hypertension due to scleroderma complicated by postcapillary pulmonary hypertension.

Congestive heart failure (Greenwich, Conn.)

Volumn 11, Issue 6, 2005, Pages 331-334

  Zakir, Ramzan M ^a   Berkowitz, Robert L ^a   Saric, Muhamed ^a   Ashtyani, Hormoz ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; PROSTACYCLIN;

ARTICLE; CASE REPORT; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DYSPNEA; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG EDEMA; LUNG WEDGE PRESSURE; MIDDLE AGED; PULMONARY HYPERTENSION; RISK ASSESSMENT; SYSTEMIC SCLEROSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSPNEA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EPOPROSTENOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY EDEMA; PULMONARY WEDGE PRESSURE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644875427     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2005.02809.x     Document Type: Article

References (0)